UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1

The EMBO journal, 1991-08, Vol.10 (8), p.2247-2258

1991

Volltextzugriff (PDF)

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers

British journal of cancer, 2006-01, Vol.94 (1), p.128-135

2006

Volltextzugriff (PDF)

BiTEs: bispecific antibody constructs with unique anti-tumor activity

Drug discovery today, 2005-09, Vol.10 (18), p.1237-1244

2005

Volltextzugriff (PDF)

Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells

Molecular immunology, 2006-02, Vol.43 (6), p.763-771

2006

Volltextzugriff (PDF)

Nuclear factor kappa B, a mediator of lipopolysaccharide effects

Immunobiology (1979), 1993-04, Vol.187 (3-5), p.233-256

1993

Volltextzugriff (PDF)

NF-κB: Ten Years After

Cell, 1996-10, Vol.87 (1), p.13-20

1996

Volltextzugriff (PDF)

A revival of bispecific antibodies

Trends in biotechnology (Regular ed.), 2004-05, Vol.22 (5), p.238-244

2004

Volltextzugriff (PDF)

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct

International journal of cancer, 2005-05, Vol.115 (1), p.98-104

2005

Volltextzugriff (PDF)

Function and activation of NF-κB in the immune system

Annual review of immunology, 1994, Vol.12, p.141-179

1994

Volltextzugriff (PDF)

MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors

Molecular Immunology, 2006-03, Vol.43 (8), p.1129-1143

2006

Volltextzugriff (PDF)

Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody

International journal of cancer, 2002-08, Vol.100 (6), p.690-697

2002

Volltextzugriff (PDF)

Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines

British journal of cancer, 2005-01, Vol.92 (2), p.342-349

2005

Volltextzugriff (PDF)

Constitutive nuclear NF-kappa B in cells of the monocyte lineage

Biochemical journal, 1994-11, Vol.304 ( Pt 1) (1), p.87-94

1994

Volltextzugriff (PDF)

Combined transcriptome and genome analysis of single micrometastatic cells

Nature biotechnology, 2002-04, Vol.20 (4), p.387-392

2002

Volltextzugriff (PDF)

H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor

The EMBO journal, 1993-05, Vol.12 (5), p.2005-2015

1993

Volltextzugriff (PDF)

T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct

The Journal of immunology (1950), 2003-04, Vol.170 (8), p.4397-4402

2003

Volltextzugriff (PDF)

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G

Molecular Immunology, 2006-03, Vol.43 (8), p.1183-1193

2006

Volltextzugriff (PDF)

NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules

Advances in immunology, 1997, Vol.65, p.111-137

1997

Volltextzugriff (PDF)

Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct

Cancer research (Chicago, Ill.), 2005-04, Vol.65 (7), p.2882-2889

2005

Volltextzugriff (PDF)

A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF‐kappa B

The EMBO journal, 1995-06, Vol.14 (11), p.2580-2588

1995

Volltextzugriff (PDF)

The ER-overload response: activation of NF-κB

Trends in Biochemical Sciences, 1997-02, Vol.22 (2), p.63-67

1997

Volltextzugriff (PDF)

Role of nuclear factor-kappa B in atherogenesis

Experimental physiology, 1997-03, Vol.82 (2), p.297-304

1997

Volltextzugriff (PDF)

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

Cancer Immunology, Immunotherapy, 2006-05, Vol.55 (5), p.503-514

2006

Volltextzugriff (PDF)

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

The Journal of clinical investigation, 1996-04, Vol.97 (7), p.1715-1722

1996

Volltextzugriff (PDF)

Molecular Mechanisms in Down-Regulation of Tumor Necrosis Factor Expression

Proceedings of the National Academy of Sciences - PNAS, 1990-12, Vol.87 (24), p.9563-9567

1990

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(128)

Sprache

Englisch
(128)

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Life Sciences & Biomedicine
(118)
Humans
(98)
Biochemistry & Molecular Biology
(66)
Animals
(63)
Biological And Medical Sciences
(61)
Molecular Sequence Data
(53)
Base Sequence
(49)
Nf-Kappa B - Metabolism
(47)
Fundamental And Applied Biological Sciences. Psychology
(40)
Cell Biology
(33)
Cell Line
(27)
Mice
(27)
Immunology
(24)
Molecular And Cellular Biology
(24)
Medical Sciences
(21)
Amino Acid Sequence
(19)
Dna - Metabolism
(19)
Cells, Cultured
(18)
Dna-Binding Proteins - Metabolism
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers

BiTEs: bispecific antibody constructs with unique anti-tumor activity

Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells

Nuclear factor kappa B, a mediator of lipopolysaccharide effects

NF-κB: Ten Years After

A revival of bispecific antibodies

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct

Function and activation of NF-κB in the immune system

MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors

Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody

Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines

Constitutive nuclear NF-kappa B in cells of the monocyte lineage

Combined transcriptome and genome analysis of single micrometastatic cells

H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor

T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G

NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules

Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct

A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF‐kappa B

The ER-overload response: activation of NF-κB

Role of nuclear factor-kappa B in atherogenesis

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

Molecular Mechanisms in Down-Regulation of Tumor Necrosis Factor Expression

Aktive Filter

Suchergebnisse filtern